Diagnosis and treatment of spine and spinal cord tumors in the era of molecular pathological diagnosis

Abstract

With the publication of the "2021 World Health Organization Classification of Tumors of the Central Nervous System (fifth edition)" (hereinafter referred to as the 2021 version of tumor classification), a new model of histological and molecular integrated diagnosis of central nervous system tumors pathology has been initiated. Based on the 2021 version of tumor classification, this review focuses on the progress of molecular pathological diagnosis and treatment of spinal cord astrocytoma, spinal ependymoma, spinal cord hemangioblastoma, spinal meningioma and spinal notochordal tumors, in order to realize the advancement of the clinical treatment and the basic research of spine and spinal cord tumors with the times.

doi：10.3969/j.issn.1672⁃6731.2022.08.001